Correlations between apolipoprotein E ε4 gene dose and whole brain atrophy rates

Kewei Chen, Eric M. Reiman, Gene E Alexander, Richard J. Caselli, Richard Gerkin, Daniel Bandy, Alisa Domb, David Osborne, Nick Fox, William R. Crum, Ann M. Saunders, John Hardy

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Objective: The purpose of this study was to characterize the relationship between whole brain atrophy rates and three levels of genetic risk for Alzheimer's disease in cognitively normal persons. The authors previously found accelerated whole brain atrophy rates in patients with probable Alzheimer's disease by computing changes in brain volume from sequential magnetic resonance images (MRIs). Methods: The authors assessed 36 late-middle-aged persons from three genetic groups: those with two, one, and no copies of the apolipoprotein E (APOE) ε4 allele, a common Alzheimer's disease susceptibility gene. The participants had clinical ratings, neuropsychological tests, and volumetric T1-weighted MRIs during a baseline visit and again approximately 2 years later. Two different image-analysis techniques, brain boundary shift integration and iterative principal component analysis, were used to compute whole brain atrophy rates. Results: While there were no baseline, follow-up, or between-visit differences in the clinical ratings or neuropsychological test scores among the three subject groups, whole brain atrophy rates were significantly greater in the ε4 homozygote group than in noncarriers and were significantly correlated with ε4 gene dose (i.e., the number of ε4 alleles in a person's APOE genotype). Conclusion: Since APOE ε4 gene dose is associated with an increased risk of Alzheimer's disease and a younger median age at dementia onset, this study suggests an association between the risk of Alzheimer's disease and accelerated brain atrophy rates before the onset of cognitive impairment.

Original languageEnglish (US)
Pages (from-to)916-921
Number of pages6
JournalAmerican Journal of Psychiatry
Volume164
Issue number6
DOIs
StatePublished - Jun 2007
Externally publishedYes

Fingerprint

Apolipoprotein E4
Atrophy
Alzheimer Disease
Brain
Genes
Neuropsychological Tests
Magnetic Resonance Spectroscopy
Alleles
Disease Susceptibility
Homozygote
Apolipoproteins E
Principal Component Analysis
Age of Onset
Dementia
Genotype

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Correlations between apolipoprotein E ε4 gene dose and whole brain atrophy rates. / Chen, Kewei; Reiman, Eric M.; Alexander, Gene E; Caselli, Richard J.; Gerkin, Richard; Bandy, Daniel; Domb, Alisa; Osborne, David; Fox, Nick; Crum, William R.; Saunders, Ann M.; Hardy, John.

In: American Journal of Psychiatry, Vol. 164, No. 6, 06.2007, p. 916-921.

Research output: Contribution to journalArticle

Chen, K, Reiman, EM, Alexander, GE, Caselli, RJ, Gerkin, R, Bandy, D, Domb, A, Osborne, D, Fox, N, Crum, WR, Saunders, AM & Hardy, J 2007, 'Correlations between apolipoprotein E ε4 gene dose and whole brain atrophy rates', American Journal of Psychiatry, vol. 164, no. 6, pp. 916-921. https://doi.org/10.1176/appi.ajp.164.6.916
Chen, Kewei ; Reiman, Eric M. ; Alexander, Gene E ; Caselli, Richard J. ; Gerkin, Richard ; Bandy, Daniel ; Domb, Alisa ; Osborne, David ; Fox, Nick ; Crum, William R. ; Saunders, Ann M. ; Hardy, John. / Correlations between apolipoprotein E ε4 gene dose and whole brain atrophy rates. In: American Journal of Psychiatry. 2007 ; Vol. 164, No. 6. pp. 916-921.
@article{a6e28fee277546ebbd10ec88a446d55d,
title = "Correlations between apolipoprotein E ε4 gene dose and whole brain atrophy rates",
abstract = "Objective: The purpose of this study was to characterize the relationship between whole brain atrophy rates and three levels of genetic risk for Alzheimer's disease in cognitively normal persons. The authors previously found accelerated whole brain atrophy rates in patients with probable Alzheimer's disease by computing changes in brain volume from sequential magnetic resonance images (MRIs). Methods: The authors assessed 36 late-middle-aged persons from three genetic groups: those with two, one, and no copies of the apolipoprotein E (APOE) ε4 allele, a common Alzheimer's disease susceptibility gene. The participants had clinical ratings, neuropsychological tests, and volumetric T1-weighted MRIs during a baseline visit and again approximately 2 years later. Two different image-analysis techniques, brain boundary shift integration and iterative principal component analysis, were used to compute whole brain atrophy rates. Results: While there were no baseline, follow-up, or between-visit differences in the clinical ratings or neuropsychological test scores among the three subject groups, whole brain atrophy rates were significantly greater in the ε4 homozygote group than in noncarriers and were significantly correlated with ε4 gene dose (i.e., the number of ε4 alleles in a person's APOE genotype). Conclusion: Since APOE ε4 gene dose is associated with an increased risk of Alzheimer's disease and a younger median age at dementia onset, this study suggests an association between the risk of Alzheimer's disease and accelerated brain atrophy rates before the onset of cognitive impairment.",
author = "Kewei Chen and Reiman, {Eric M.} and Alexander, {Gene E} and Caselli, {Richard J.} and Richard Gerkin and Daniel Bandy and Alisa Domb and David Osborne and Nick Fox and Crum, {William R.} and Saunders, {Ann M.} and John Hardy",
year = "2007",
month = "6",
doi = "10.1176/appi.ajp.164.6.916",
language = "English (US)",
volume = "164",
pages = "916--921",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "6",

}

TY - JOUR

T1 - Correlations between apolipoprotein E ε4 gene dose and whole brain atrophy rates

AU - Chen, Kewei

AU - Reiman, Eric M.

AU - Alexander, Gene E

AU - Caselli, Richard J.

AU - Gerkin, Richard

AU - Bandy, Daniel

AU - Domb, Alisa

AU - Osborne, David

AU - Fox, Nick

AU - Crum, William R.

AU - Saunders, Ann M.

AU - Hardy, John

PY - 2007/6

Y1 - 2007/6

N2 - Objective: The purpose of this study was to characterize the relationship between whole brain atrophy rates and three levels of genetic risk for Alzheimer's disease in cognitively normal persons. The authors previously found accelerated whole brain atrophy rates in patients with probable Alzheimer's disease by computing changes in brain volume from sequential magnetic resonance images (MRIs). Methods: The authors assessed 36 late-middle-aged persons from three genetic groups: those with two, one, and no copies of the apolipoprotein E (APOE) ε4 allele, a common Alzheimer's disease susceptibility gene. The participants had clinical ratings, neuropsychological tests, and volumetric T1-weighted MRIs during a baseline visit and again approximately 2 years later. Two different image-analysis techniques, brain boundary shift integration and iterative principal component analysis, were used to compute whole brain atrophy rates. Results: While there were no baseline, follow-up, or between-visit differences in the clinical ratings or neuropsychological test scores among the three subject groups, whole brain atrophy rates were significantly greater in the ε4 homozygote group than in noncarriers and were significantly correlated with ε4 gene dose (i.e., the number of ε4 alleles in a person's APOE genotype). Conclusion: Since APOE ε4 gene dose is associated with an increased risk of Alzheimer's disease and a younger median age at dementia onset, this study suggests an association between the risk of Alzheimer's disease and accelerated brain atrophy rates before the onset of cognitive impairment.

AB - Objective: The purpose of this study was to characterize the relationship between whole brain atrophy rates and three levels of genetic risk for Alzheimer's disease in cognitively normal persons. The authors previously found accelerated whole brain atrophy rates in patients with probable Alzheimer's disease by computing changes in brain volume from sequential magnetic resonance images (MRIs). Methods: The authors assessed 36 late-middle-aged persons from three genetic groups: those with two, one, and no copies of the apolipoprotein E (APOE) ε4 allele, a common Alzheimer's disease susceptibility gene. The participants had clinical ratings, neuropsychological tests, and volumetric T1-weighted MRIs during a baseline visit and again approximately 2 years later. Two different image-analysis techniques, brain boundary shift integration and iterative principal component analysis, were used to compute whole brain atrophy rates. Results: While there were no baseline, follow-up, or between-visit differences in the clinical ratings or neuropsychological test scores among the three subject groups, whole brain atrophy rates were significantly greater in the ε4 homozygote group than in noncarriers and were significantly correlated with ε4 gene dose (i.e., the number of ε4 alleles in a person's APOE genotype). Conclusion: Since APOE ε4 gene dose is associated with an increased risk of Alzheimer's disease and a younger median age at dementia onset, this study suggests an association between the risk of Alzheimer's disease and accelerated brain atrophy rates before the onset of cognitive impairment.

UR - http://www.scopus.com/inward/record.url?scp=34250801552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250801552&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.164.6.916

DO - 10.1176/appi.ajp.164.6.916

M3 - Article

C2 - 17541051

AN - SCOPUS:34250801552

VL - 164

SP - 916

EP - 921

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 6

ER -